We are live on
!
Find out more
Acadia Pharmaceuticals
ACAD
ACAD
222 hedge funds and large institutions have $2.48B invested in Acadia Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 81 increasing their positions, 66 reducing their positions, and 46 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% more funds holding in top 10
Funds holding in top 10: 2 → 4 (+2)
52% more call options, than puts
Call options by funds: $11.2M | Put options by funds: $7.41M
23% more repeat investments, than reductions
Existing positions increased: 81 | Existing positions reduced: 66
17% more capital invested
Capital invested by funds: $2.12B → $2.48B (+$359M)
0.72% more ownership
Funds ownership: 93.46% → 94.18% (+0.72%)
9% less funds holding
Funds holding: 245 → 222 (-23)
50% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 46
Holders
222
Holders Change
-23
Holders Change %
-9.39%
% of All Funds
3.82%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.07%
New
23
Increased
81
Reduced
66
Closed
46
Calls
$11.2M
Puts
$7.41M
Net Calls
+$3.83M
Net Calls Change
-$4.05M
